Memantine: Reality and Potentiality
DOI:
https://doi.org/10.33393/dti.2008.1331Keywords:
memantine, NMDA, glutamate, degenerationAbstract
Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of cholinergic neurons in the CNS induced by injection of NMDA into the basal forebrain of rats. It has been shown that memantine induced production of brain-derived neurotrophic factor (BDNF), a substance shown to promote survival and differentiation of CNS neuron. Due to the preclinical effects of memantine owing to its anti-ischemic and anti-excitotoxic properties, recent clinical efficacy has been demonstrated in patients with advanced dementia of vascular origins. Therefore, it has been employed in different trials, in vascular dementia, showing a potential benefit and no unbearable side effects. Different studies underline the possible role of memantine in Parkinson Disease.Downloads
Download data is not yet available.
Downloads
Published
2008-05-08
How to Cite
Moretti, R., Torre, P., Vilotti, C., Manganaro, D., Zanet, L., & Antonello, R. M. (2008). Memantine: Reality and Potentiality. Drug Target Insights, 3(1). https://doi.org/10.33393/dti.2008.1331
Issue
Section
Review